The amount of sugar in the brain plays a key role in governing the activity of oligodendrocytes, the brain cells…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Eating greater amounts of ultra-processed foods is significantly linked to a higher likelihood of developing multiple sclerosis (MS) in…
Brain inflammation is often viewed as harmful in neurological diseases such as multiple sclerosis (MS), but a new animal…
Regulators in the European Union are recommendeding that tolebrutinib be approved as a treatment for people with secondary…
A team of scientists in China, attempting to understand the function of a genetic mutation commonly found in animals living…
Physical exercise may help reduce inflammation in multiple sclerosis (MS) by changing the activity of immune T-cells, a new…
The first participant has been dosed in a Phase 1 clinical trial testing TNV262, an experimental therapy that Tenvie…
A history of infectious mononucleosis, often called “mono,” more than triples the risk of developing multiple sclerosis (MS), according…
A pair of studies showed that a group of nerve cells essential for cognition may be…
In multiple sclerosis (MS), certain disease-driving immune cells carry a protein marker called CD29, which helps them move into…
A new model of nerve fibers may serve as a platform to screen for experimental treatments that can promote myelin…
The cells that line the inside of the gut — known as intestinal epithelial cells — may play a key…
A new study being funded by the National Multiple Sclerosis Society (NMSS) will seek to better understand how women with…
Variations in the activity of a protein called p21 may underlie the differences in the activity of myelin-repairing cells in…
Exercises to strengthen the respiratory muscles — the muscles in the chest needed to move air in and out of…
For people with multiple sclerosis (MS) on Ocrevus (ocrelizumab) whose disease is well controlled after at least a year…
Most people with multiple sclerosis (MS) have persistently high levels of antibodies against Epstein-Barr virus (EBV), but these…
Although the total number of people living with multiple sclerosis (MS) has increased globally in recent decades due to…
A “molecular atlas” of disease that can predict illness years before symptoms appear is the goal of a massive new…
Long-term exposure to air pollution may increase the risk of developing multiple sclerosis (MS), while short-term exposure may worsen…
A test that measures a specific set of proteins in cerebrospinal fluid (CSF) — the liquid that surrounds the brain…
Fenebrutinib, Genentech’s investigational BTK inhibitor, was found to significantly reduce relapse rates compared with the approved therapy Aubagio…
A specific pattern of damage seen on MRI scans, called a paramagnetic rim lesion, is associated with a higher risk…
Treatment with the experimental nasal spray therapy foralumab reduced microglial activity in people with nonactive secondary progressive multiple sclerosis…
Having parents who have ever smoked cigarettes, or who smoked in the three months before pregnancy, is associated with a…
Myelin-making cells in some areas of the brain were more resistant to injury in a mouse model of myelin damage…
Following specific diets may help reduce inflammation in people with multiple sclerosis (MS), but more research is needed,…
A type of immune cell that has received little attention in multiple sclerosis (MS) research may play a key…
A three-year study of GA Depot, a monthly injection for primary progressive multiple sclerosis (PPMS), found that most patients…
A new study suggests that how certain immune cells respond to Mavenclad (cladribine) may help explain why…